PRE-TRANSPLANT CHEMOTHERAPY DOES NOT AFFECT POST TRANSPLANT OUTCOME IN PATIENTS UNDERGOING OHT FOR AL CARDIOMYOPATHY

Light-chain (AL) cardiac amyloidosis can be treated with cardiac transplantation (HT) followed by high dose melphalan chemotherapy and autologous stem cell transplant. We hypothesized that chemotherapy (CTX) prior to HT targeting clonal plasma cell light chain production may lead to improved